Alliance for Clinical Trials in Oncology
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
- Conditions
- Interventions
- First Posted Date
- 2004-03-25
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 100
- Registration Number
- NCT00006348
- Locations
- πΊπΈ
CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States
πΊπΈRapid City Regional Hospital, Rapid City, South Dakota, United States
πΊπΈAltru Health Systems, Grand Forks, North Dakota, United States
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2004-03-24
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 73
- Registration Number
- NCT00005972
- Locations
- πΊπΈ
Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States
πΊπΈUniversity of Chicago Cancer Research Center, Chicago, Illinois, United States
πΊπΈMarlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
- First Posted Date
- 2004-03-15
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 51
- Registration Number
- NCT00003704
- Locations
- πΊπΈ
CentraCare Clinic, Saint Cloud, Minnesota, United States
π¨π¦Allan Blair Cancer Centre, Regina, Saskatchewan, Canada
πΊπΈSiouxland Hematology-Oncology, Sioux City, Iowa, United States
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
- First Posted Date
- 2004-03-09
- Last Posted Date
- 2016-12-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 70
- Registration Number
- NCT00079118
- Locations
- πΊπΈ
Kenton Oncology, Incorporated, Kenton, Ohio, United States
πΊπΈMcDonough District Hospital, Macomb, Illinois, United States
πΊπΈHurley Medical Center, Flint, Michigan, United States
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
- First Posted Date
- 2004-03-09
- Last Posted Date
- 2020-05-12
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 645
- Registration Number
- NCT00079001
- Locations
- πΊπΈ
Good Samaritan Hospital of Maryland, Baltimore, Maryland, United States
πΊπΈGreenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
πΊπΈFisher-Titus Medical Center, Norwalk, Ohio, United States
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
- Conditions
- Interventions
- First Posted Date
- 2004-03-08
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 48
- Registration Number
- NCT00006467
- Locations
- πΊπΈ
CCOP - Carle Cancer Center, Urbana, Illinois, United States
πΊπΈSiouxland Hematology-Oncology, Sioux City, Iowa, United States
πΊπΈCCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach
- Conditions
- Interventions
- First Posted Date
- 2004-03-03
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 47
- Registration Number
- NCT00004235
- Locations
- πΊπΈ
CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States
πΊπΈMedcenter One Health System, Bismarck, North Dakota, United States
πΊπΈCCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
- First Posted Date
- 2004-03-01
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 104
- Registration Number
- NCT00003351
- Locations
- πΊπΈ
CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
πΊπΈCCOP - Wichita, Wichita, Kansas, United States
πΊπΈSiouxland Hematology-Oncology, Sioux City, Iowa, United States
Capecitabine in Treating Patients With Malignant Mesothelioma
- First Posted Date
- 2004-02-25
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 27
- Registration Number
- NCT00004183
- Locations
- πΊπΈ
University of Chicago Cancer Research Center, Chicago, Illinois, United States
πΊπΈCCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York, United States
πΊπΈUniversity of Illinois at Chicago Health Sciences Center, Chicago, Illinois, United States
Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- First Posted Date
- 2004-02-20
- Last Posted Date
- 2016-07-20
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 587
- Registration Number
- NCT00003299
- Locations
- πΊπΈ
CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States
πΊπΈCCOP - Carle Cancer Center, Urbana, Illinois, United States
πΊπΈCCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States